Table 2.
The best overall response (FAS, dose-expansion part).
Parameters | All patients n = 35, n (%) |
95% CI |
---|---|---|
Best overall response | ||
Complete response (CR) | 0 | – |
Partial response (PR) | 0 | – |
Stable disease (SD) | 19 (54.3) | – |
Progressive disease (PD) | 14 (40.0) | – |
Unknown | 2 (5.7) | – |
Clinical benefit rate (CBR): CR + PR + SD ≥ 16 weeks | 10 (28.6) | 14.6–46.3 |
Overall response rate (ORR): CR + PR | 0 | 0–10.0 |
Disease control rate (DCR): CR + PR + SD | 19 (54.3) | 36.6–71.2 |
CI confidence interval, FAS full-analysis set.